Error loading player: No playable sources found

Panel Discussion with Regulators and Closing Remarks

Date
September 24, 2021
Explore related products in the following collection:

Speakers

Speaker Image for Wilson Bryan
Director, Office of Tissues and Advanced Therapies, CBER/FDA
Speaker Image for Matthew Davis
Senior GMP Inspector - Inspections Team Leader, Therapeutic Goods Administration
Speaker Image for Alyce Maksoud
Team Leader Inspection Section, PIC/S Chair, Tissue & Cells , Australian Government Department of Health (TGA)
Speaker Image for René Thürmer
Quality Assessor, BfArm
Speaker Image for Thomas Hartman
President and CEO, ISPE

Related Products

Thumbnail for Panel Discussion with the Keynote Speakers and Closing Remarks
Panel Discussion with the Keynote Speakers and Closing Remarks
Panel Discussion with the Keynote Speakers and Closing Remarks|
Thumbnail for Update PIC/S Annex 2A for ATMPs Revision and PIC/S on Cell and Tissues
Update PIC/S Annex 2A for ATMPs Revision and PIC/S on Cell and Tissues
Update PIC/S Annex 2A for ATMPs Revision and PIC/S on Cell and Tissues |
Thumbnail for Track 4: Cell and Gene Therapy, ATMPs, Data Science Research and Development
Thumbnail for Regulatory Aspects for ATMPs, based on PIC/S Annex 2 2A and EU GMP Annex 1
Regulatory Aspects for ATMPs, based on PIC/S Annex 2 2A and EU GMP Annex 1
Regulatory Aspects for ATMPs, based on PIC/S Annex 2 2A and EU GMP Annex 1|

Copyright © 2025 International Society for Pharmaceutical Engineering
Powered by Conexiant DXP